Suppr超能文献

《运动障碍治疗前沿:从证据到治疗与应用:满足共济失调患者管理需求》

CRPD frontiers in movement disorders Therapeutics: From evidence to treatment and applications: Addressing Patients' Needs in the Management of the Ataxias.

作者信息

Perlman Susan L

机构信息

Department of Neurology David Geffen School of Medicine at UCLA Health Sciences 300 UCLA Medical Plaza, Suite B200 Los Angeles, CA 90095, United States.

出版信息

Clin Park Relat Disord. 2024 May 10;10:100255. doi: 10.1016/j.prdoa.2024.100255. eCollection 2024.

Abstract

The genetic ataxias have no cures and no proven ways to delay progression (no disease-modifying therapies). The acquired ataxias may have treatments that address the underlying cause and may slow or stop progression, but will not reverse damage already sustained. The idiopathic ataxias (of unknown genetic or acquired cause) also have no proven disease-modifying therapies. However, for all patients with ataxia of any cause, there is always something that can be done to improve quality of life-treat associated symptoms, provide information and resources, counsel patient and family, help with insurance and disability concerns, be available to listen and answer the many questions they will have.

摘要

遗传性共济失调无法治愈,也没有经证实的延缓疾病进展的方法(没有疾病修饰疗法)。获得性共济失调可能有针对潜在病因的治疗方法,可能会减缓或阻止疾病进展,但无法逆转已造成的损害。特发性共济失调(病因不明的遗传性或获得性)也没有经证实的疾病修饰疗法。然而,对于所有因任何原因导致共济失调的患者,总有一些事情可以做来改善生活质量——治疗相关症状、提供信息和资源、为患者及其家人提供咨询、帮助解决保险和残疾问题、随时倾听并回答他们会提出的众多问题。

相似文献

2
Symptom burden of people with progressive ataxia, and its wider impact on their friends and relatives: a cross-sectional study.
AMRC Open Res. 2021 Nov 30;3:28. doi: 10.12688/amrcopenres.13036.1. eCollection 2021.
3
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809.
4
Treatable Ataxias: How to Find the Needle in the Haystack?
J Mov Disord. 2022 Sep;15(3):206-226. doi: 10.14802/jmd.22069. Epub 2022 Sep 7.
5
[Ataxias. Diagnostic procedure and treatment].
Nervenarzt. 2005 Oct;76(10):1275-83; quiz 1284-5. doi: 10.1007/s00115-005-1992-8.
6
Parkinsonism & related disorders. Ataxias.
Parkinsonism Relat Disord. 2007;13 Suppl 3:S391-4. doi: 10.1016/S1353-8020(08)70036-1.
7
EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.
Eur J Neurol. 2014 Apr;21(4):552-62. doi: 10.1111/ene.12341. Epub 2014 Jan 13.
8
Cerebellar and afferent ataxias.
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1312-43. doi: 10.1212/01.CON.0000436158.39285.22.
9
Guidelines on the diagnosis and management of the progressive ataxias.
Orphanet J Rare Dis. 2019 Feb 20;14(1):51. doi: 10.1186/s13023-019-1013-9.
10

引用本文的文献

1
Frontiers in movement disorder therapeutics: A new era in neurology.
Clin Park Relat Disord. 2024 Jul 18;12:100263. doi: 10.1016/j.prdoa.2024.100263. eCollection 2025.

本文引用的文献

1
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data.
Ann Clin Transl Neurol. 2024 Jan;11(1):4-16. doi: 10.1002/acn3.51897. Epub 2023 Sep 10.
2
ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization.
Genome Med. 2023 Sep 7;15(1):68. doi: 10.1186/s13073-023-01214-2.
4
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias.
Am J Hum Genet. 2023 Jul 6;110(7):1098-1109. doi: 10.1016/j.ajhg.2023.05.009. Epub 2023 Jun 9.
6
Systematic assessment of plasma biomarkers in spinocerebellar ataxia.
Neurobiol Dis. 2023 Jun 1;181:106112. doi: 10.1016/j.nbd.2023.106112. Epub 2023 Mar 30.
7
8
Motor neuron involvement threatens survival in spinocerebellar ataxia type 1.
Neuropathol Appl Neurobiol. 2023 Apr;49(2):e12897. doi: 10.1111/nan.12897.
9
Ataxias: Hereditary, Acquired, and Reversible Etiologies.
Semin Neurol. 2023 Feb;43(1):48-64. doi: 10.1055/s-0043-1763511. Epub 2023 Feb 24.
10
Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia.
Expert Opin Investig Drugs. 2023 Jan;32(1):5-16. doi: 10.1080/13543784.2023.2173063. Epub 2023 Feb 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验